awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38089883-B59BA5E5-08AA-444B-8931-7B393674E5E8
Q38089883-B59BA5E5-08AA-444B-8931-7B393674E5E8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38089883-B59BA5E5-08AA-444B-8931-7B393674E5E8
HER dimerization inhibitors: developing pertuzumab as an anticancer agent in women's oncology.
P2860
Q38089883-B59BA5E5-08AA-444B-8931-7B393674E5E8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38089883-B59BA5E5-08AA-444B-8931-7B393674E5E8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
941986fdd29d92fa14a63ebbbc31084871518685
P2860
A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumours.